The French National Agency for the Safety of Medicines and Health Products (ANSM) Archives

Home Tags The French National Agency for the Safety of Medicines and Health Products (ANSM)

MB Therapeutics cleared to manufacture cartridges for 3D printed drugs

Kety S. - October 1, 2026

The French National Agency for the Safety of Medicines and Health Products (ANSM) has granted French company MB Therapeutics the authorization to open a...

About

Published by KEYMAR Solutions, 3D ADEPT Media is a trade press that tracks and analyses the latest trends in the additive manufacturing industry. As a source for high-quality, accurate, and timely additive manufacturing resources, we pride ourselves on delivering up-to-date information you can rely on through our online media and our print & interactive digital magazine 3D ADEPT Mag.

We love to think that this industry delivers “glocalized” manufacturing solutions to industries (in a nutshell, solutions that are both global and local). That is why we work with collaborators and partners across the world so that industries can easily identify the manufacturing path that best fits their needs. Learn more

CONTACT US : 3D ADEPT MEDIA by KEYMAR SOLUTIONS SRL – VAT: BE0681.599.796
Rue Borrens 51 – 1050 Brussels
Email: contact@3dadept.com
Tel: +32(0)486745887

MB Therapeutics cleared to manufacture cartridges for 3D printed drugs

ORNL & Boeing 3D print a 2-ton stamp form die mold

Carbon’s dual-cure patent survives appeal in Europe

Constructor AI opens free public test of its browser-based “design without CAD” tool

MB Therapeutics cleared to manufacture cartridges for 3D printed drugs

ORNL & Boeing 3D print a 2-ton stamp form die mold

Škoda releases free 3D-printable accessories for its cars

Nike 3D prints its fastest vortex generators yet for Keely Hodgkinson’s one-of-one speed suit

Over one year after the implementation of tariff measures, how have companies adjusted?

The right moment in AM: When machine manufacturers should launch and AM users should invest

How is the industry tackling densification challenges in additively manufactured technical ceramics?

When the technology is ready, but the system is not: Reimbursement pathways for 3D printing in Europe

Post-processing of polymer 3D printed parts: service, afterthought, or business on its own?

Understanding scalable simulation and optimization for production metal AM

How to create an AM quality data infrastructure that strengthens AI credibility

1,200 solutions, zero patents: TOM’s 3D printing model for accessible assistive technology

Fewer parts, more complexity: Why depowdering is emerging as a key enabler in electric vehicles’ manufacturing

How do you qualify large-format AM parts in industrial environments? The case of LSAM

How LCM enabled a monolithic ceramic gyroid that delivers five times the power-to-weight ratio of conventional solid oxide fuel cells

Beyond the print: Why 3D planning may be the most underrated tool in modern surgery

Formnext 2026 program puts defense, post-processing and standards in the spotlight

Vicenzaoro 2026 expands global reach: 136 countries and double‑digit international growth

Registration for 2027 AMUG conference is now open

Hybrid Manufacturing: Additive freedom, metalworking quality

Tag: The French National Agency for the Safety of Medicines and Health Products (ANSM)

MB Therapeutics cleared to manufacture cartridges for 3D printed drugs